NEW! Investment Companies Centre
American Express Platinum Cashback Card:
£29.79m
-1.00p ()
41.50p
Date: Thursday 07 Aug 2008
LONDON (ShareCast) - Cancer diagnostic group Genetix posted a modest rise in half year pre-tax profit and a 19% hike in revenue as it continues to trade in line with expectations.
Pre-tax profit rose to £1.11m for the six months to 30 June 2008 compared with £1.05m the year before on revenue of £12.37m as its major markets grow. The gross margin improved to 61% from 58.5%.
"Genetix has enjoyed a good first half, delivering strong organic revenue growth and cash generation whilst also investing significantly in our sales infrastructure, building an enlarged network to capitalise on growth in our major markets," said chief executive Mark Reid.
An interim dividend of 0.2 pence per share has been declared.
| Currency | UK Pounds |
| Share Price | 41.50p ![]() |
| Change Today | -1.00p |
| 52 Week High | 62.50 |
| 52 Week Low | 35.00 |
| Volume | 0 |
| Shares Issued | 71.78m |
| Market Cap | £29.79m |
| Beta | 0.11 |
| RiskGrade | 187 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Price Chg 6m |
|
|---|
| P/E |
|
|---|
| PEG |
|
|---|
| Dividend Yield |
|
|---|
| EPS Growth |
|
|---|
| Operating Margin |
|
|---|
| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 13-Aug-08 | 07-May-08 |
| Paid | 12-Sep-08 | 09-Jun-08 |
| Amount | 0.20p | 0.50p |
| Finance Director | Andrew Kellett |
| CEO | Charles de Rohan |